Suksham Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Suksham Jain has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Deepak Chawla
Department of Neonatology, Government Medical College and Hospital, Chandigarh, India
11 shared publicationsSupreet Khurana
Department of Neonatology, Government Medical College and Hospital, Chandigarh, India
8 shared publications- Deepak Chawla
Department of Neonatology, Government Medical College & Hospital, Chandigarh, India
6 shared publications Abhishek Yadav
Department of Neonatology, Government Medical College & Hospital, Chandigarh, India
2 shared publications- Arnav Hari
Department of Electrical Engineering, Indian Institute of Technology Ropar, Rupnagar, Punjab, India
2 shared publications Atul Kumar Jha
Department of Neonatology, Government Medical College Hospital, Chandigarh, India
2 shared publications
Latest Publications
- 11 June 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (8) , 902
Effect of Prone Positioning on Ventilation in Preterm Neonates – A Randomized Controlled Trial: Authors’ Reply
- 11 June 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (8) , 902
Effect of Prone Positioning on Ventilation in Preterm Neonates – A Randomized Controlled Trial: Authors’ Reply
- 14 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 263
Original research: surfactant administration using less invasive surfactant administration (LISA) versus enhanced intubate–surfactant–extubate (ENSURE) in preterm infants
Surfactant replacement therapy improves outcomes in preterm neonates with respiratory distress syndrome (RDS). While the less invasive surfactant administration (LISA) technique offers advantages over intubate–surfactant–extubate (INSURE), the enhanced INSURE (ENSURE) technique has been proposed to address procedural limitations of INSURE. However, direct comparisons between LISA and ENSURE are limited. This study aimed to compare the effectiveness of LISA and ENSURE in reducing the need for mechanical ventilation within 72 h in preterm neonates with RDS. In this open-label, single-center randomized controlled trial conducted at a tertiary-care hospital in North India, 118 preterm neonates (gestational age 26–35 weeks) requiring surfactant therapy were randomized to receive either LISA or ENSURE. The primary outcome was the need for invasive mechanical ventilation within 72 h of surfactant administration. Secondary outcomes included duration of respiratory support, ventilator-free days, intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD), mortality, and other neonatal morbidities. Baseline characteristics, including gestational age (30.6 vs. 31.3 weeks), birth weight (1442 vs. 1537 g), use of antenatal steroids (91.5% vs. 94.9%), were comparable between the two groups. The need for invasive mechanical ventilation within 72 h was similar in the LISA and ENSURE groups (32.2% vs. 33.9%; relative risk 0.95, 95% CI 0.57–1.59; p = 0.845). The duration of respiratory support, incidence of BPD, and mortality was also comparable. Conclusion: LISA did not reduce the need for invasive mechanical ventilation within 72 h, duration of respiratory support, or neonatal morbidities and mortality compared with ENSURE. Trial registration: Clinical Trial Registry of India (CTRI/2023/07/055841). What is Known: •LISA reduces mechanical ventilation and BPD compared with conventional INSURE by preserving spontaneous breathing and avoiding prolonged positive pressure ventilation. •However, consistent superiority over other surfactant delivery techniques has not been demonstrated, with outcomes influenced by technique, expertise, patient selection, and protocol variability. What is New: •ENSURE showed comparable effectiveness to LISA in reducing invasive mechanical ventilation within 72 h. •These findings underscore that a standardized, protocol-driven surfactant strategy may be as important as the choice of technique.
- 14 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 263
Original research: surfactant administration using less invasive surfactant administration (LISA) versus enhanced intubate–surfactant–extubate (ENSURE) in preterm infants
Surfactant replacement therapy improves outcomes in preterm neonates with respiratory distress syndrome (RDS). While the less invasive surfactant administration (LISA) technique offers advantages over intubate–surfactant–extubate (INSURE), the enhanced INSURE (ENSURE) technique has been proposed to address procedural limitations of INSURE. However, direct comparisons between LISA and ENSURE are limited. This study aimed to compare the effectiveness of LISA and ENSURE in reducing the need for mechanical ventilation within 72 h in preterm neonates with RDS. In this open-label, single-center randomized controlled trial conducted at a tertiary-care hospital in North India, 118 preterm neonates (gestational age 26–35 weeks) requiring surfactant therapy were randomized to receive either LISA or ENSURE. The primary outcome was the need for invasive mechanical ventilation within 72 h of surfactant administration. Secondary outcomes included duration of respiratory support, ventilator-free days, intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD), mortality, and other neonatal morbidities. Baseline characteristics, including gestational age (30.6 vs. 31.3 weeks), birth weight (1442 vs. 1537 g), use of antenatal steroids (91.5% vs. 94.9%), were comparable between the two groups. The need for invasive mechanical ventilation within 72 h was similar in the LISA and ENSURE groups (32.2% vs. 33.9%; relative risk 0.95, 95% CI 0.57–1.59; p = 0.845). The duration of respiratory support, incidence of BPD, and mortality was also comparable. Conclusion: LISA did not reduce the need for invasive mechanical ventilation within 72 h, duration of respiratory support, or neonatal morbidities and mortality compared with ENSURE. Trial registration: Clinical Trial Registry of India (CTRI/2023/07/055841). What is Known: •LISA reduces mechanical ventilation and BPD compared with conventional INSURE by preserving spontaneous breathing and avoiding prolonged positive pressure ventilation. •However, consistent superiority over other surfactant delivery techniques has not been demonstrated, with outcomes influenced by technique, expertise, patient selection, and protocol variability. What is New: •ENSURE showed comparable effectiveness to LISA in reducing invasive mechanical ventilation within 72 h. •These findings underscore that a standardized, protocol-driven surfactant strategy may be as important as the choice of technique.
- 14 March 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (5) , 498-504
Effect of Prone Positioning on Ventilation in Preterm Neonates – A Randomized Controlled Trial
- 14 March 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (5) , 498-504
Effect of Prone Positioning on Ventilation in Preterm Neonates – A Randomized Controlled Trial
- 20 November 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 59, 101023
Antimicrobial resistance in blood culture proven sepsis in outborn and inborn neonates
- 20 November 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 59, 101023
Antimicrobial resistance in blood culture proven sepsis in outborn and inborn neonates
- 30 July 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (9) , 648-654
Estimation of Depth of Endotracheal Tube Insertion Using Gestational Age, Body Weight or Nasal–Tragus Length in Newborns: An Open-Label Randomized Controlled Trial
Objectives Optimal placement of an endotracheal tube (ETT) tip is necessary for safe and effective ventilation of the lungs. However, there is no consensus on the most accurate method for calculating the depth of ET insertion. To compare the accuracy (proportion of optimally placed ETT) of nasal–tragus length (NTL)-based formula, body weight-based formula, and gestational age (GA)-based method in estimating the depth of oral ETT insertion in neonates. Methods Neonates of gestational age 250/7–41+6 weeks undergoing oral endotracheal intubation during the first 28 days of life were randomized into one of three study groups. The depth of ETT insertion was determined using gestational age-based (Kempley), weight-based (Tochen), or NTL-based methods. The optimal position of the ETT tip, assessed by a blinded radiologist on an anteroposterior chest radiograph, was considered to be between the upper border of T1 and the lower border of T2. Results In this study, 165 neonates (55 per group) were included. Birth weight, gestational age, proportion of small-for-gestational age neonates, and other baseline characteristics were similar among neonates in the three groups. The rates of optimal ETT placement were not significantly different between the NTL- (47.2%), GA- (45.4%) and weight-based (43.6%) methods (P = 0.911). The corresponding rates of ETT repositioning in the NTL-, GA- and weight-based method groups based on auscultation of chest was 58%, 49% and 29%, respectively (P < 0.001). Conclusion No significant difference was observed in the accuracy of the three methods studied. Better methods are needed to calculate the depth of ETT insertion. Trial Registration Prospectively registered with the Clinical Trial Registry of India (CTRI/2022/12/048221).
- 30 July 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (9) , 648-654
Estimation of Depth of Endotracheal Tube Insertion Using Gestational Age, Body Weight or Nasal–Tragus Length in Newborns: An Open-Label Randomized Controlled Trial
Objectives Optimal placement of an endotracheal tube (ETT) tip is necessary for safe and effective ventilation of the lungs. However, there is no consensus on the most accurate method for calculating the depth of ET insertion. To compare the accuracy (proportion of optimally placed ETT) of nasal–tragus length (NTL)-based formula, body weight-based formula, and gestational age (GA)-based method in estimating the depth of oral ETT insertion in neonates. Methods Neonates of gestational age 250/7–41+6 weeks undergoing oral endotracheal intubation during the first 28 days of life were randomized into one of three study groups. The depth of ETT insertion was determined using gestational age-based (Kempley), weight-based (Tochen), or NTL-based methods. The optimal position of the ETT tip, assessed by a blinded radiologist on an anteroposterior chest radiograph, was considered to be between the upper border of T1 and the lower border of T2. Results In this study, 165 neonates (55 per group) were included. Birth weight, gestational age, proportion of small-for-gestational age neonates, and other baseline characteristics were similar among neonates in the three groups. The rates of optimal ETT placement were not significantly different between the NTL- (47.2%), GA- (45.4%) and weight-based (43.6%) methods (P = 0.911). The corresponding rates of ETT repositioning in the NTL-, GA- and weight-based method groups based on auscultation of chest was 58%, 49% and 29%, respectively (P < 0.001). Conclusion No significant difference was observed in the accuracy of the three methods studied. Better methods are needed to calculate the depth of ETT insertion. Trial Registration Prospectively registered with the Clinical Trial Registry of India (CTRI/2022/12/048221).
- Open Access
- 5 June 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (7) , 534-536
Is Shorter (3–4 Days) Antibiotic Therapy Adequate Compared to Standard (5–7 Days) Duration in Neonates with Suspected (Culture Negative) Sepsis? No
- 5 June 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (7) , 534-536
Open AccessIs Shorter (3–4 Days) Antibiotic Therapy Adequate Compared to Standard (5–7 Days) Duration in Neonates with Suspected (Culture Negative) Sepsis? No
- 2 May 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (6) , 616-621
T-piece resuscitator versus self-inflating bag for resuscitation in the delivery room in preterm neonates: a randomised controlled trial
Objective To compare the efficacy of T-piece resuscitator (TPR) and self-inflating bag (SIB) for resuscitation of preterm neonates in the delivery room. Settings Level III neonatal intensive care unit in North India. Design Open-label, parallel-group, randomised controlled trial. Patient Preterm neonates of>26–34 weeks of gestation requiring positive pressure ventilation (PPV) at birth. Intervention Neonates needing PPV at birth were identified using Neonatal Resuscitation Programme guidelines, 2020, and resuscitated using either TPR or SIB as per permuted block random sequence. Main outcome measures Primary outcome was need for delivery room endotracheal intubation. Secondary outcomes were duration of PPV, oxygen saturation (SpO2) at 2 and 5 min, time to spontaneous respiration and heart rate>100 beats per minute. Results Mean gestation age (weeks; 30±2.1 vs 31±2) and birth weight (g; 1400±408 vs 1450±427) were comparable. Of the total 120, 8 (13.7%) in the TPR group versus 19 (30.6%) neonates in the SIB group were intubated in the delivery room (risk difference (95% CI), −0.16 (–0.31 to −0.02); p=0.03). SpO2 mean (SD) at 5 min in TPR group and SIB group were 82.9±8.7% and 78.9±12.1%, respectively; mean difference (95% CI), 3.99 (0.15 to 7.83); p=0.04). Median (IQR) of combined Apgar at 5 min in TPR group and SIB group were 13 (12–14) and 12 (10–13), p 0.02. Other outcomes were comparable. Conclusion TPR is more efficacious than SIB in terms of lesser delivery room intubation and better SpO2 at 5 min in preterm neonates.
- 2 May 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (6) , 616-621
T-piece resuscitator versus self-inflating bag for resuscitation in the delivery room in preterm neonates: a randomised controlled trial
Objective To compare the efficacy of T-piece resuscitator (TPR) and self-inflating bag (SIB) for resuscitation of preterm neonates in the delivery room. Settings Level III neonatal intensive care unit in North India. Design Open-label, parallel-group, randomised controlled trial. Patient Preterm neonates of>26–34 weeks of gestation requiring positive pressure ventilation (PPV) at birth. Intervention Neonates needing PPV at birth were identified using Neonatal Resuscitation Programme guidelines, 2020, and resuscitated using either TPR or SIB as per permuted block random sequence. Main outcome measures Primary outcome was need for delivery room endotracheal intubation. Secondary outcomes were duration of PPV, oxygen saturation (SpO2) at 2 and 5 min, time to spontaneous respiration and heart rate>100 beats per minute. Results Mean gestation age (weeks; 30±2.1 vs 31±2) and birth weight (g; 1400±408 vs 1450±427) were comparable. Of the total 120, 8 (13.7%) in the TPR group versus 19 (30.6%) neonates in the SIB group were intubated in the delivery room (risk difference (95% CI), −0.16 (–0.31 to −0.02); p=0.03). SpO2 mean (SD) at 5 min in TPR group and SIB group were 82.9±8.7% and 78.9±12.1%, respectively; mean difference (95% CI), 3.99 (0.15 to 7.83); p=0.04). Median (IQR) of combined Apgar at 5 min in TPR group and SIB group were 13 (12–14) and 12 (10–13), p 0.02. Other outcomes were comparable. Conclusion TPR is more efficacious than SIB in terms of lesser delivery room intubation and better SpO2 at 5 min in preterm neonates.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.
- Open Access
- 25 February 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e59532
Contactless Breathing Monitoring at Home and in the Hospital: Protocol for a Low-Cost Frequency-Modulated Continuous-Wave Radar-Based Device
Background: Contactless monitoring of vital signs, especially the breathing of children, in the hospital is performed on a priority basis because their organs and immune system are immature. Therefore, continuous monitoring of their vital signs with a sensor that is directly attached to their body is not possible, as it irritates the sensitive newborn skin and causes discomfort. A contactless frequency-modulated continuous-wave (FMCW) radar-based device can wirelessly monitor the breathing rate and pattern of a child in the hospital or at home. Signal-processing capability can be added to this device to process breathing data and analyze the apnea condition arising due to irregular breathing patterns. Objective: This study will develop a contactless FMCW radar-based system to accurately monitor the breathing rate and pattern of neonates and infants in hospitals and at home in order to provide a noninvasive, nonintrusive and contactless alternative to conventional sensor-based methods and address a critical need in neonatal care, potentially improving health outcomes for vulnerable infants. Methods: The radar transmits a signal toward the body, and the time taken by the signal received to travel from the body to the receiving antenna is analyzed. This time is proportional to the distance between the radar and the body, and the breathing pattern is recognized as a slight, periodic variation in this distance. We will use this concept with multiple antenna systems to monitor the breathing of neonates with improved sensitivity. The radar-based device will be installed, in addition to conventional breathing monitors, in the neonatal intensive care unit. The signals received at the radar and the respiration signals from conventional monitors will be recorded in a database. Signal-processing techniques will be applied to extract breathing signals from the signals received at the radar. Results: This study was funded in January 2023 by the Science and Engineering Research Board (SERB) of India. The device was designed by May 2024, and a working proof-of concept was verified in the Indian Institute of Technology (IIT) Ropar laboratory. Implementation of the proposed method for initial study began in December 2024. Results are expected to be published in the first quarter of 2025. Conclusions: The contactless FMCW radar-based system will provide reliable estimation of the breathing rate and pattern, which is close to the conventional reference device values most of the time. Our device will also provide a seamless breathing-monitoring system to be used both in hospitals and at home for newborns and premature babies until they are fully healthy and fit. International Registered Report Identifier (IRRID): PRR1-10.2196/59532
- 25 February 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e59532
Open AccessContactless Breathing Monitoring at Home and in the Hospital: Protocol for a Low-Cost Frequency-Modulated Continuous-Wave Radar-Based Device
Background: Contactless monitoring of vital signs, especially the breathing of children, in the hospital is performed on a priority basis because their organs and immune system are immature. Therefore, continuous monitoring of their vital signs with a sensor that is directly attached to their body is not possible, as it irritates the sensitive newborn skin and causes discomfort. A contactless frequency-modulated continuous-wave (FMCW) radar-based device can wirelessly monitor the breathing rate and pattern of a child in the hospital or at home. Signal-processing capability can be added to this device to process breathing data and analyze the apnea condition arising due to irregular breathing patterns. Objective: This study will develop a contactless FMCW radar-based system to accurately monitor the breathing rate and pattern of neonates and infants in hospitals and at home in order to provide a noninvasive, nonintrusive and contactless alternative to conventional sensor-based methods and address a critical need in neonatal care, potentially improving health outcomes for vulnerable infants. Methods: The radar transmits a signal toward the body, and the time taken by the signal received to travel from the body to the receiving antenna is analyzed. This time is proportional to the distance between the radar and the body, and the breathing pattern is recognized as a slight, periodic variation in this distance. We will use this concept with multiple antenna systems to monitor the breathing of neonates with improved sensitivity. The radar-based device will be installed, in addition to conventional breathing monitors, in the neonatal intensive care unit. The signals received at the radar and the respiration signals from conventional monitors will be recorded in a database. Signal-processing techniques will be applied to extract breathing signals from the signals received at the radar. Results: This study was funded in January 2023 by the Science and Engineering Research Board (SERB) of India. The device was designed by May 2024, and a working proof-of concept was verified in the Indian Institute of Technology (IIT) Ropar laboratory. Implementation of the proposed method for initial study began in December 2024. Results are expected to be published in the first quarter of 2025. Conclusions: The contactless FMCW radar-based system will provide reliable estimation of the breathing rate and pattern, which is close to the conventional reference device values most of the time. Our device will also provide a seamless breathing-monitoring system to be used both in hospitals and at home for newborns and premature babies until they are fully healthy and fit. International Registered Report Identifier (IRRID): PRR1-10.2196/59532
- 10 January 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 53, 100782
Skin colonization by pathogenic bacteria as a risk factor for neonatal sepsis
- 10 January 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 53, 100782
Skin colonization by pathogenic bacteria as a risk factor for neonatal sepsis